About the Authors

Nicholas C. D’Amato

Contributed equally to this work with: Nicholas C. D’Amato, Julie H. Ostrander

Affiliation Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, United States of America

Julie H. Ostrander

Contributed equally to this work with: Nicholas C. D’Amato, Julie H. Ostrander

Affiliation Department of Medicine, University of Minnesota Masonic Cancer Center, Minneapolis, MInnesota, United States of America

Michelle L. Bowie

Affiliation Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

Christopher Sistrunk

Affiliation Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

Alexander Borowsky

Affiliation Center for Comparative Medicine, University of California Davis, Davis, California, United States of America

Robert D. Cardiff

Affiliation Center for Comparative Medicine, University of California Davis, Davis, California, United States of America

Katie Bell

Affiliation Center for Comparative Medicine, University of California Davis, Davis, California, United States of America

Lawrence J. T. Young

Affiliation Center for Comparative Medicine, University of California Davis, Davis, California, United States of America

Karl Simin

Affiliation Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

Robin E. Bachelder

Affiliation Department of Pathology, Duke University, Durham, North Carolina, United States of America

Jeff Delrow

Affiliation Genomics Resource, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Alyssa Dawson

Affiliation Genomics Resource, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Lisa D. Yee

Affiliation Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

Krzysztof Mrózek

Affiliation Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

Timothy M. Clay

Affiliation Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

Takuya Osada

Affiliation Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America

Victoria L. Seewaldt

seewa001@mc.duke.edu

Affiliation Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

Competing Interests

The authors have read the journal’s policy and have the following conflicts: NCD, JHO, and VLS currently have a provisional patent application pending for the DKAT cell line, United States Patent Application No. 12/901,292 entitled “DKAT Cell Line, a Model for Human Triple-Negative Breast Cancer.” This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: NCD JHO TO TMC RDC REB LDY VLS CS AB KB. Performed the experiments: NCD JHO CS AB KB TO RDC LJTY JD AD KM MLB LDY VLS REB. Analyzed the data: NCD JHO TO TMC RDC LJTY JD AD KS KM AB KB CS VLS. Contributed reagents/materials/analysis tools: TO TMC RDC LJTY JD AD KS KM AB KB REB VLS. Wrote the paper: NCD JHO VLS CS AB.